Werewolf Therapeutics (HOWL) Current Assets (2020 - 2026)

Werewolf Therapeutics (HOWL) has reported Current Assets for 7 consecutive years, with $22.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets fell 71.54% year-over-year to $22.9 million in Q2 2026; TTM through Jun 2026 was $22.9 million, a 71.54% decrease from a year earlier, with the FY2025 full-year figure at $58.6 million, down 48.18% from the prior year.
• Current Assets was $22.9 million for Q2 2026 at Werewolf Therapeutics, down from $48.7 million in the prior quarter.
• Over five years, Current Assets peaked at $156.6 million in Q1 2023 and troughed at $22.9 million in Q2 2026.
• A 5-year average of $114.8 million and a median of $138.6 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 71.37% in 2022 and slumped 71.54% in 2026, its largest moves.
• Over 5 years, Current Assets stood at $140.2 million in 2022, then retreated by 1.31% to $138.4 million in 2023, then slipped by 18.29% to $113.1 million in 2024, then sank by 48.18% to $58.6 million in 2025, then slumped by 60.93% to $22.9 million in 2026.
• The last three Current Assets figures came in at $22.9 million (Q2 2026), $48.7 million (Q1 2026), and $58.6 million (Q4 2025), per Business Quant data.